Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_assertion type Assertion NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_head.
- NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_assertion description "[Among the investigated CD44 splice variants expression of exon v6 is the most promising prognostic marker in surgically treated cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_provenance.
- NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_assertion evidence source_evidence_literature NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_provenance.
- NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_assertion SIO_000772 7539775 NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_provenance.
- NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_assertion wasDerivedFrom befree-20150227 NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_provenance.
- NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_assertion wasGeneratedBy ECO_0000203 NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_provenance.